Skip to main content
. Author manuscript; available in PMC: 2023 Mar 1.
Published in final edited form as: Alcohol Clin Exp Res. 2022 Feb 17;46(3):477–491. doi: 10.1111/acer.14780

Table 1:

Descriptive Statistics Across Treatment Group

Naltrexone Placebo
1. Treatment Condition 47% (N=54) 53% (N=61)
2. Family History 41% Positive 36% Positive
3. Sex 70% Male 67% Male
4. Medication Dosage 73% Both Pills 63% Both Pills
5. Weekend (day) 56% Weekends 61% Weekends
6. Drinking Quantity 4.46 (2.93) 5.74 (3.85)
7. Buzzed SR 3.94 (3.09) 4.38 (3.22)
8. Drunk SR 2.32 (2.76) 3.29 (3.26)
9. Impaired SR 1.78 (2.51) 2.72 (3.07)
10. Craving 5.93 (1.54) 5.72 (1.58)

Note: All between-person descriptive statistics are aggregated at the person level (N=115), whereas all within-person descriptives are aggregated at the daily level (N=1543). SR = subjective response. Variables 4-10 were measured during the dialy diary protocol.